DEUTSCHE BANK AG\
BankPosition in ALXO — Alx Oncology Holdings Inc
CIK 948046
FRANKFURT AM MAIN, 2M
Position in ALXO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$222,375
+$159,383 QoQ
Shares Held
107,428
+6.2% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 94 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. ALXO ranks #230 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in ALXO
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $222,375 | 107,428 | Shares | Defined | 2026-08-07 | |
| 2025-03-31 | $62,992 | 101,113 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $168,857 | 101,113 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $29,634 | 16,283 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $62,916 | 10,434 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $128,090 | 11,488 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $165,606 | 11,122 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $51,786 | 10,789 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $1,452,997 | 193,475 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,567,484 | 346,789 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,858,340 | 342,355 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,274,978 | 342,213 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,765,315 | 341,819 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $5,807,904 | 343,663 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $245,415 | 11,420 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $1,153,913 | 15,623 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $615,860 | 11,263 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $855,973 | 11,608 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $614,777 | 7,132 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $192,775 | 5,108 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||